What is the appropriate pediatric dosing of dimenhydrinate (Gravol) for children, including dose per kilogram, maximum single and daily doses, dosing interval, and age restrictions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dimenhydrinate (Gravol) Dosing

For children requiring dimenhydrinate, administer 1.25 mg/kg intramuscularly or intravenously every 6 hours, with a maximum daily dose of 300 mg, though this medication should be used cautiously given its limited benefit and potential to delay diagnosis of serious conditions. 1

Weight-Based Dosing

  • Standard dose: 1.25 mg/kg per dose administered every 6 hours (four times daily) 1
  • Alternative calculation: 37.5 mg/m² of body surface area four times daily 1
  • Maximum daily dose: 300 mg regardless of weight 1

Route of Administration

  • Intramuscular (IM): Each milliliter (50 mg) injected as needed 1
  • Intravenous (IV): Each milliliter (50 mg) must be diluted in 10 mL of 0.9% Sodium Chloride and injected over 2 minutes 1
  • Oral/rectal formulations: Available but specific pediatric dosing not detailed in FDA labeling 1

Dosing Interval

  • Every 4-6 hours as needed for nausea and vomiting control 1
  • Duration of action is approximately 4 hours per 50 mg adult dose 1

Age and Safety Considerations

Toxicity Thresholds

  • Children under 6 years: Refer to emergency department if ingestion ≥7.5 mg/kg 2
  • Children 6 years and older: Refer to emergency department if ingestion ≥7.5 mg/kg or 300 mg (whichever is less) 2

Important Clinical Caveats

Risk of diagnostic delay: Dimenhydrinate use is associated with delayed presentation (>12 hours after symptom onset) and can mask serious conditions including asthma, pelvic inflammatory disease, and urinary tract infection 3

Limited clinical benefit: While dimenhydrinate reduces vomiting frequency (69.6% vomiting-free vs 47.4% placebo), it does not improve oral rehydration success, weight gain, or clinical outcomes in children with gastroenteritis 4

Seizure risk with repeated dosing: Case reports document generalized tonic-clonic seizures in infants receiving repeated suppository doses (23 mg/kg over 2 days), particularly when defecation is intermittent and drug accumulates 5

Practical Dosing Examples

For a 20 kg child:

  • Single dose = 1.25 mg/kg × 20 kg = 25 mg per dose
  • Maximum frequency = every 6 hours
  • Maximum daily = 300 mg (12 doses theoretically, but limited to 4 doses/day per FDA guidance) 1

For a 10 kg child:

  • Single dose = 1.25 mg/kg × 10 kg = 12.5 mg per dose
  • Every 6 hours as needed 1

When to Avoid or Use Cautiously

  • Do not use in children with suicidal intent, intentional abuse, or suspected malicious intent 2
  • Avoid when vomiting may indicate a treatable medical condition requiring prompt diagnosis 3
  • Consider alternatives (such as ondansetron) given dimenhydrinate's modest efficacy and potential for diagnostic delay 4, 3
  • Monitor closely if using rectal formulations repeatedly, as accumulation can occur 5

Monitoring After Administration

  • Observe for 6 hours post-ingestion if therapeutic dosing; if asymptomatic at 6 hours, emergency referral not needed 2
  • Watch for excessive drowsiness, agitation, seizures, or respiratory depression warranting immediate emergency department referral 2
  • Assess whether vomiting cessation allows successful oral rehydration 4

References

Research

Diagnostic delay after dimenhydrinate use in vomiting children.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1991

Research

[How safe are dimenhydrinate suppositories?].

Deutsche medizinische Wochenschrift (1946), 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.